Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 7
2016 11
2017 25
2018 26
2019 27
2020 23
2021 21
2022 27
2023 11

Text availability

Article attribute

Article type

Publication date

Search Results

149 results

Results by year

Filters applied: . Clear all
Page 1
A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia.
Mascarenhas J, Kosiorek HE, Prchal JT, Rambaldi A, Berenzon D, Yacoub A, Harrison CN, McMullin MF, Vannucchi AM, Ewing J, O'Connell CL, Kiladjian JJ, Mead AJ, Winton EF, Leibowitz DS, De Stefano V, Arcasoy MO, Kessler CM, Catchatourian R, Rondelli D, Silver RT, Bacigalupo A, Nagler A, Kremyanskaya M, Levine MF, Arango Ossa JE, McGovern E, Sandy L, Salama ME, Najfeld V, Tripodi J, Farnoud N, Penson AV, Weinberg RS, Price L, Goldberg JD, Barbui T, Marchioli R, Tognoni G, Rampal RK, Mesa RA, Dueck AC, Hoffman R. Mascarenhas J, et al. Among authors: kosiorek he. Blood. 2022 May 12;139(19):2931-2941. doi: 10.1182/blood.2021012743. Blood. 2022. PMID: 35007321 Free PMC article. Clinical Trial.
Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea.
Yacoub A, Mascarenhas J, Kosiorek H, Prchal JT, Berenzon D, Baer MR, Ritchie E, Silver RT, Kessler C, Winton E, Finazzi MC, Rambaldi A, Vannucchi AM, Leibowitz D, Rondelli D, Arcasoy MO, Catchatourian R, Vadakara J, Rosti V, Hexner E, Kremyanskaya M, Sandy L, Tripodi J, Najfeld V, Farnoud N, Papaemmanuil E, Salama M, Singer-Weinberg R, Rampal R, Goldberg JD, Barbui T, Mesa R, Dueck AC, Hoffman R. Yacoub A, et al. Among authors: kosiorek h. Blood. 2019 Oct 31;134(18):1498-1509. doi: 10.1182/blood.2019000428. Blood. 2019. PMID: 31515250 Free PMC article. Clinical Trial.
Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer.
McDonald BR, Contente-Cuomo T, Sammut SJ, Odenheimer-Bergman A, Ernst B, Perdigones N, Chin SF, Farooq M, Mejia R, Cronin PA, Anderson KS, Kosiorek HE, Northfelt DW, McCullough AE, Patel BK, Weitzel JN, Slavin TP, Caldas C, Pockaj BA, Murtaza M. McDonald BR, et al. Among authors: kosiorek he. Sci Transl Med. 2019 Aug 7;11(504):eaax7392. doi: 10.1126/scitranslmed.aax7392. Sci Transl Med. 2019. PMID: 31391323 Free PMC article.
Association of Telehealth with Short-Interval Follow-Up.
Chavez A, Pullins C, Yennie J, Singh C, Kosiorek H. Chavez A, et al. Among authors: kosiorek h. J Am Board Fam Med. 2022 May-Jun;35(3):485-490. doi: 10.3122/jabfm.2022.03.210520. J Am Board Fam Med. 2022. PMID: 35641054 Free article.
Symptom burden and quality of life in patients with high-risk essential thrombocythaemia and polycythaemia vera receiving hydroxyurea or pegylated interferon alfa-2a: a post-hoc analysis of the MPN-RC 111 and 112 trials.
Mazza GL, Mead-Harvey C, Mascarenhas J, Yacoub A, Kosiorek HE, Hoffman R, Dueck AC, Mesa RA; Myeloproliferative Neoplasms Research Consortium (MPN-RC) 111 and 112 trial teams. Mazza GL, et al. Among authors: kosiorek he. Lancet Haematol. 2022 Jan;9(1):e38-e48. doi: 10.1016/S2352-3026(21)00343-4. Lancet Haematol. 2022. PMID: 34971581 Free PMC article. Clinical Trial.
Surveillance Imaging After MRI-Guided Benign Breast Biopsies.
Patel BK, Chen T, Newell M, Kosiorek HE, Loving V, D'orsi C. Patel BK, et al. Among authors: kosiorek he. J Am Coll Radiol. 2019 Jul;16(7):936-939. doi: 10.1016/j.jacr.2018.12.001. Epub 2019 Feb 8. J Am Coll Radiol. 2019. PMID: 30745039 No abstract available.
Is There a Relationship Between TILs and Regression in Melanoma?
Morrison S, Han G, Elenwa F, Vetto JT, Fowler G, Leong SP, Kashani-Sabet M, Pockaj B, Kosiorek HE, Zager JS, Messina JL, Mozzillo N, Schneebaum S, Han D; Sentinel Lymph Node Working Group. Morrison S, et al. Among authors: kosiorek he. Ann Surg Oncol. 2022 May;29(5):2854-2866. doi: 10.1245/s10434-021-11251-z. Epub 2022 Jan 21. Ann Surg Oncol. 2022. PMID: 35064332
149 results